Peter van Sluis
Impact in
- Neurology top 0.5%
- Neuroblastoma Research and Treatments
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 29
- Neuroblastoma Research and Treatments 29
-
- Ubiquitin and proteasome pathways 3
- Cell death mechanisms and regulation 3
- FOXO transcription factor regulation 2
- Protein Degradation and Inhibitors 2
- Co-authors
- Rogier Versteeg (34 shared papers)Huib N. Caron (18 shared papers)Jan Köster (14 shared papers)Kathy Boon (6 shared papers)P.A. Voûte (6 shared papers)Jan J. Molenaar (8 shared papers)Linda J. Valentijn (4 shared papers)Jan de Kraker (6 shared papers)
- Journals
- Genes Chromosomes and Cancer (7 papers)Oncogene (3 papers)Cancer Research (3 papers)Human Genetics (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Peter van Sluis
35 papers receiving 3.6k citations
Peter van Sluis's Hit Papers
Peers
Comparison fields: 5 of 101
- Neurology 1.5k
- Cancer Research 788
- Genetics 397
- Molecular Biology 2.4k
- Oncology 502
Countries citing papers authored by Peter van Sluis
This map shows the geographic impact of Peter van Sluis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter van Sluis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter van Sluis more than expected).
Fields of papers citing papers by Peter van Sluis
This network shows the impact of papers produced by Peter van Sluis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter van Sluis. The network helps show where Peter van Sluis may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter van Sluis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Human Transcriptome Map: Clustering of Highly Expressed Genes in Chromosomal Domains Hit paper breakdown → | 2001 | 606 |
| 2 | Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features Hit paper breakdown → | 2008 | 527 |
| 3 | 2001 | 361 | |
| 4 | 1996 | 344 | |
| 5 | 2015 | 269 | |
| 6 | 2012 | 170 | |
| 7 | 2008 | 141 | |
| 8 | 1995 | 131 | |
| 9 | 2013 | 120 | |
| 10 | 2004 | 107 | |
| 11 | 2019 | 99 | |
| 12 | 2007 | 66 | |
| 13 | 2006 | 65 | |
| 14 | 2002 | 63 | |
| 15 | 2001 | 61 | |
| 16 | 2003 | 59 | |
| 17 | Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. | 1994 | 58 |
| 18 | 2011 | 55 | |
| 19 | 2000 | 52 | |
| 20 | 1996 | 50 |
About Peter van Sluis
Peter van Sluis is a scholar working on Neurology, Molecular Biology, Cancer Research, Cell Biology and Genetics, having authored 35 papers that have together received 3.7k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (29 papers), Cancer, Hypoxia, and Metabolism (12 papers), Microtubule and mitosis dynamics (4 papers), Ubiquitin and proteasome pathways (3 papers), Cell death mechanisms and regulation (3 papers), Neuroendocrine Tumor Research Advances (3 papers), FOXO transcription factor regulation (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Neurology (1.5k citations), Cancer Research (788 citations), Genetics (397 citations), Molecular Biology (2.4k citations) and Oncology (502 citations). Peter van Sluis has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Rogier Versteeg, Huib N. Caron, Jan Köster, Kathy Boon, P.A. Voûte, Jan J. Molenaar, Linda J. Valentijn, Jan de Kraker, Frank Baas and Nancy E. Hasselt. Their work appears in journals such as Genes Chromosomes and Cancer, Oncogene, Cancer Research, Human Genetics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.